Provincial Industry Payer Agreements Roundtable

About the Provincial Industry Payer Agreements Roundtable

5 May 2013
St. John's, Newfoundland

The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable was a follow-up to a 2011 National Roundtable Discussion on Innovative Approaches to Industry-Payer Agreements held in Vancouver, British Columbia in association with the Canadian Agency for Drugs and Technologies in Health (CADTH) Annual Symposium. Information on the 2011 meeting:

Innovative Industry Payer Agreements: A National Discussion

This half-day invitational roundtable was part of the IHE's ongoing Methodology Forum series supported by the Institute of Health Economics, the Alberta government, and industry partners, AstraZeneca, Merck, and Eli Lilly. The event brought together academic experts, industry leaders and senior decision makers. The presentations and discussion were intended to promote a common understanding of the current landscape, allow frank discussion and sharing of perspectives and identification of key issues to support future areas of focus and policy development.

Download Final Report 
Provincial Industry-Payer Agreements in an Era of National Pricing Strategies – National Roundtable – Final Report
Download Backgrounder 
Industry-Payor Agreements for Pharmaceuticals: Backgrounder

The objectives of this roundtable were to:

  1. Discuss the current and potential state of the industry-payer agreements and price negotiation in Canada.
  2. Articulate opportunities and barriers and future areas for policy development.

The session was conducted using Chatham House rules. Participants agreed not to report comments attributed to specific individuals.

Chair and moderator:
Dr. Chris Henshall, Chair, Health Technology Assessment International Policy Forum

Dr. Anderson Chuck, Director of Economic Evaluation and Analytics, Institute of Health Economics